Antibiotic resistant gonorrhoea cases are on the rise

Contributed by: UK Government and Public Sector

Tags

Government

STI

More Like This

Swiss-based Non-profit GARDP Supports the Development of Debiopharm’s New Potential Treatment for Gonorrhoea

CARB-X Awards Additional Funding to Debiopharm for Continued Development of Early-Stage Antibiotic Targeting Drug-Resistant N. Gonorrhoeae Infections

Tuberculosis levels in England increased by 11% in 2023

Intravacc Awarded US$ 633K CARB-X Funding to Develop a Vaccine that Prevents Gonorrhea Infections

New report from Access to Medicine Foundation shows what pharma companies can do to ensure the few promising antimicrobials in development reach patients on the frontlines of drug resistance

Over 3 million children died from AMR-related infections in 2022, major study shows

LetsGetChecked Receives U.S. Food and Drug Administration (FDA) De Novo Authorization for At-Home Chlamydia and Gonorrhea Testing System

LifeArc - New UK-India research project trialling easy-to-use test to help fight against global threat of antimicrobial resistance